Home
>
US Stocks
>
Clovis Oncology Inc
Clovis Oncology Inc
CLVS

Clovis Oncology Inc

$4.354.19%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.45
Today Low/High
4.34 / 4.49
52 Week Low/High
$4.08 / $11.1
P/E ratio
-1.6787
Market Cap
$521M

Company Details

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe.
Organisation
Clovis Oncology Inc
Headquaters
Boulder, Colorado, US
Employees
429
Industry
Health Technology
CEO
Patrick Mahaffy

Discover more

Frequently Asked Questions

What is Clovis Oncology Inc share price today

Can Indians buy Clovis Oncology Inc shares?

How can I buy Clovis Oncology Inc shares from India?

Can Fractional shares of Clovis Oncology Inc be purchased?

What are the documents required to start investing in Clovis Oncology Inc stocks?

We are a SEBI registered investement advisor